In fact, Sasaki et al reported a significant decrease in regional cerebral blood flow during IFN therapy, suggesting that IFN-induced vasospasm may be responsible for the development of ischemic colitis.[7–15] Clearly, additional study of the molecular mechanisms behind IFN-induced ischemia is warranted. This evidence concerns the gene IFNA1 and ischemia.